1. Home
  2. TRN vs ACAD Comparison

TRN vs ACAD Comparison

Compare TRN & ACAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Trinity Industries Inc.

TRN

Trinity Industries Inc.

HOLD

Current Price

$26.86

Market Cap

2.2B

Sector

Industrials

ML Signal

HOLD

Logo ACADIA Pharmaceuticals Inc.

ACAD

ACADIA Pharmaceuticals Inc.

HOLD

Current Price

$26.31

Market Cap

4.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRN
ACAD
Founded
1933
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Railroads
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
4.6B
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
TRN
ACAD
Price
$26.86
$26.31
Analyst Decision
Hold
Buy
Analyst Count
1
23
Target Price
$24.00
$29.39
AVG Volume (30 Days)
572.5K
1.4M
Earning Date
02-19-2026
11-05-2025
Dividend Yield
4.69%
N/A
EPS Growth
N/A
98.53
EPS
1.14
1.54
Revenue
$2,175,100,000.00
$1,047,118,000.00
Revenue This Year
N/A
$15.16
Revenue Next Year
$5.75
$11.51
P/E Ratio
$23.23
$17.33
Revenue Growth
N/A
12.69
52 Week Low
$22.38
$13.40
52 Week High
$39.83
$28.35

Technical Indicators

Market Signals
Indicator
TRN
ACAD
Relative Strength Index (RSI) 42.58 49.77
Support Level $28.07 $26.56
Resistance Level $28.89 $28.35
Average True Range (ATR) 0.51 0.71
MACD -0.22 -0.24
Stochastic Oscillator 23.60 9.47

Price Performance

Historical Comparison
TRN
ACAD

About TRN Trinity Industries Inc.

Trinity Industries Inc. sells and leases railroad products and railcar maintenance services in North America. The company operates under the name TrinityRail in three main segments: railcar leasing and management services, which owns railcars and provides fleet management and administration services; rail products, which builds, sells, and modifies freight and tank railcars and their components; and all other, which sells highway products such as guardrail and other highway barriers. Customers include railroads, leasing companies, and shipping companies in agriculture, construction, consumer products, energy, and chemicals.

About ACAD ACADIA Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has two core franchises in neuroscience and neuro-rare diseases. The neuroscience franchise is anchored by its commercial product NUPLAZID (pimavanserin), which is used for the treatment of hallucinations and delusions associated with Parkinson's Disease Psychosis (PDP). The neuro-rare disease franchise is anchored by the commercial product DAYBUE, which is used for the treatment of Rett syndrome. In addition, the company has various product candidates under development in different stages, including ACP-204, ACP-101, ACP-211, ACP-711, ACP-2591, etc.

Share on Social Networks: